Mădălina Begu
Mădălina Begu publishes mostly in Hematology, Genetics and Rheumatology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #6,666,322 of 7,710,434 ranked researchers
- Rank in United States
- #1,543,723 of 1,627,098
- Works
- 23
- Citations
- 20
- Citations per work
- 0.9
What does Mădălina Begu research?
Mădălina Begu's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1459.3%
- Medicine1459.3%
- Everything else729.5%
- Life Sciences311.2%
- 1Hematology30% of their works
- 2Genetics17% of their works
- 3Rheumatology7% of their works
- 4Molecular Biology6% of their works
- 5Immunology6% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Acute Lymphoblastic Leukemia research
- Eosinophilic Disorders and Syndromes
- Immune Cell Function and Interaction
Which keywords describe Mădălina Begu's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, JAK2 Mutation, Minimal Residual Disease, Myelofibrosis, BCR-ABL and Imatinib.
- Natural Killer Cells
- International Myeloma Working Group
- Genomic Aberrations
- Diagnosis Criteria
- Childhood Cancer
- Imatinib
- Myelofibrosis
- JAK2 Mutation
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Minimal Residual Disease
- BCR-ABL
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Fusion Genes
- Hypereosinophilic Syndrome
- NK Cell Recognition
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors133 topics
- AML71 topic
- Acute Myeloid Leukemia71 topic
- JAK2 Mutation61 topic
- Minimal Residual Disease62 topics
- Myelofibrosis61 topic
- BCR-ABL51 topic
- Imatinib51 topic
- Acute Lymphoblastic Leukemia31 topic
- Childhood Cancer31 topic
- Chronic Lymphocytic Leukemia31 topic
- Diagnosis Criteria31 topic
- Fusion Genes31 topic
- Genomic Aberrations31 topic
- Hypereosinophilic Syndrome31 topic
- International Myeloma Working Group31 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
Where does Mădălina Begu work?
Mădălina Begu's main affiliation in the publication record is Emergency University, United States.
How many publications and citations does Mădălina Begu have?
OpenAlex counts 23 works and 20 citations for Mădălina Begu, an h-index of 3, ranking #6,666,322 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mădălina Begu. Posts are plain text and can be reported.